Vivani Medical Stock Price, News & Analysis (NASDAQ:VANI) $0.94 -0.01 (-1.05%) (As of 12/5/2023 ET) Add Compare Share Share Today's Range$0.94▼$1.0050-Day Range$0.94▼$1.1352-Week Range$0.75▼$1.89Volume26,874 shsAverage Volume48,616 shsMarket Capitalization$48.20 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media About Vivani Medical Stock (NASDAQ:VANI)Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.Read More VANI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart VANI Stock News HeadlinesNovember 18, 2023 | markets.businessinsider.comPositive Outlook for Vivani Medical: Innovative Therapies for Metabolic Diseases and Promising Drug DevelopmentsNovember 14, 2023 | benzinga.comVivani Medical: Q3 Earnings InsightsDecember 6, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comNovember 14, 2023 | msn.comVivani Medical GAAP EPS of -$0.13November 14, 2023 | finance.yahoo.comVivani Medical Provides Business Update and Reports Third Quarter Financial ResultsNovember 9, 2023 | morningstar.comVivani Medical Inc VANIOctober 31, 2023 | finance.yahoo.comVivani Medical, Inc. (VANI)October 25, 2023 | benzinga.comDirector At This Health Care Company Buys $103K of StockDecember 6, 2023 | Autonomix (Ad)How to Invest Early In the Next Potential Breakthrough Nerve-Sensing TechnologyAutonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.comOctober 25, 2023 | msn.comVivani Medical director buys over 103k shares - filingOctober 16, 2023 | finance.yahoo.comVivani Medical to Present at BIO Investor ForumOctober 3, 2023 | benzinga.comVivani Medical And 3 Other Stocks Under $2 Insiders Are BuyingSeptember 25, 2023 | benzinga.comVivani Medical And 2 Other Stocks Under $2 Insiders Are BuyingSeptember 19, 2023 | benzinga.comVivani Medical Director Trades $97K In Company StockSeptember 13, 2023 | finance.yahoo.comDirector Gregg Williams Acquires 13,997 Shares of Vivani Medical Inc (VANI)September 10, 2023 | finance.yahoo.comInsider Buys Additional US$50k In Vivani Medical StockSeptember 8, 2023 | benzinga.com50K Reasons To Be Bullish On Vivani Medical StockSeptember 8, 2023 | msn.comVivani Medical Director William Gregg buys $50.2k worth of shares - filingSeptember 7, 2023 | finance.yahoo.comVivani Medical to Present at the Boulder Peptide SymposiumSeptember 5, 2023 | finance.yahoo.comVivani Medical Subsidiary Cortigent to Present Orion Clinical Study Results at The Eye and The Chip World Research Congress on Artificial Vision October 8-10August 16, 2023 | markets.businessinsider.comMaxim Group Reaffirms Their Buy Rating on Vivani Medical (VANI)August 14, 2023 | seekingalpha.comVivani Medical GAAP EPS of -$0.13 misses by $0.02August 14, 2023 | chron.comVivani Medical: Q2 Earnings SnapshotAugust 14, 2023 | finance.yahoo.comVivani Medical Reports Second Quarter Financial Results and Provides Business UpdateJuly 11, 2023 | finance.yahoo.comVivani Medical, Inc. Subsidiary Cortigent Reports 5-Year Early Feasibility Study Update for the Orion® Visual Cortical Prosthesis SystemJune 23, 2023 | benzinga.comDirector at Vivani Medical Acquires Company Stock Options Worth 32,121 SharesJune 21, 2023 | benzinga.comBoard Member at Vivani Medical Acquires Company Stock Options Worth 32,121 SharesSee More Headlines Receive VANI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Vivani Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/14/2023Today12/05/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/29/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:VANI CUSIPN/A CIK1266806 Webwww.vivani.com Phone(818) 833-5000Fax818-833-5067Employees50Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.56) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-13,890,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-76.19% Return on Assets-51.59% Debt Debt-to-Equity RatioN/A Current Ratio4.13 Quick Ratio4.13 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.87 per share Price / Book1.09Miscellaneous Outstanding Shares51,030,000Free Float22,645,000Market Cap$48.21 million OptionableOptionable Beta2.43 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for December 2023. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Adam Mendelsohn Ph.D. (Age 41)CEO & Director Comp: $312.01kMs. Brigid Ann Makes (Age 67)Chief Financial Officer Comp: $204.63kMr. Truc Le M.B.A. (Age 70)Chief Operations Officer Comp: $337.2kDr. Lisa E. Porter M.D. (Age 59)Chief Medical Officer Comp: $208.4kMr. Donald Dwyer M.B.A.Chief Business OfficerKey CompetitorsMovanoNASDAQ:MOVEPrecision OpticsNASDAQ:POCIelectroCoreNASDAQ:ECORBioSig TechnologiesNASDAQ:BSGMNeurAxisNASDAQ:NRXSView All CompetitorsInsiders & InstitutionsGregg WilliamsBought 2,694 shares on 11/24/2023Total: $2,559.30 ($0.95/share)Gregg WilliamsBought 769 shares on 11/22/2023Total: $730.55 ($0.95/share)Donald DwyerBought 1,000 shares on 11/22/2023Total: $960.00 ($0.96/share)Donald DwyerBought 2,500 shares on 11/20/2023Total: $2,400.00 ($0.96/share)Gregg WilliamsBought 2,015 shares on 11/16/2023Total: $1,914.25 ($0.95/share)View All Insider TransactionsView All Institutional Transactions VANI Stock Analysis - Frequently Asked Questions How have VANI shares performed in 2023? Vivani Medical's stock was trading at $0.8497 at the start of the year. Since then, VANI stock has increased by 11.2% and is now trading at $0.9447. View the best growth stocks for 2023 here. When is Vivani Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Friday, March 29th 2024. View our VANI earnings forecast. How were Vivani Medical's earnings last quarter? Vivani Medical, Inc. (NASDAQ:VANI) released its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.13) earnings per share for the quarter, meeting analysts' consensus estimates of ($0.13). Who are Vivani Medical's major shareholders? Vivani Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include Cutler Group LLC CA (0.00%) and Concourse Financial Group Securities Inc. (0.00%). Insiders that own company stock include Aaron Mendelsohn, Brigid Makes, Donald Dwyer, Gregg Williams and Joachim Eberhard Bolck. View institutional ownership trends. How do I buy shares of Vivani Medical? Shares of VANI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. This page (NASDAQ:VANI) was last updated on 12/6/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vivani Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.